JAMA Surgery : Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS
- Author
- American Medical Association, 2017
- Published
- Mon 23 Oct 2023
- Episode Link
- https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jamasurg.2023.5502
Interview with Seema A. Khan, MD, author of Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial. Hosted by Amalia Cochran, MD.
Related Content:
